On the mBC Phase 1/2 clinical trial in combination trial.
"This trial will be initiated once GMP RC220 is available, and after the completion of toxicology studies, ethics submission, and regulatory approvals. The expected timeframe for trial commencement is Q3 CY 2024."
Another 12 months before recruitment begins...
Ann: Race Strategic Update August 2023, page-7
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.45 |
Change
0.000(0.00%) |
Mkt cap ! $242.9M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5000 | $1.49 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.40 | 2342 | 2 |
View Market Depth
| Last trade - 09.55am 30/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.43 |
Change
0.000 ( 0.09 %) |
||||
| Open | High | Low | Volume | ||
| $1.43 | $1.43 | $1.43 | 282 | ||
| Last updated 10.12am 30/05/2024 ? | |||||
| RAC (ASX) Chart |
Day chart unavailable